New hope for stubborn gout: experimental drug PRX-115 enters phase 2 trial
Disease control
Recruiting now
This study tests a new medicine called PRX-115, given through a vein, to see if it can lower uric acid levels in adults with gout who haven't improved with standard pills. About 150 participants will receive either PRX-115 (with or without methotrexate) or a placebo over 24 weeks…
Phase: PHASE2 • Sponsor: Protalix • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC